| 臺大學術典藏 |
2020-11-02T02:04:13Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Helicobacter Consortium; Taiwan Gastrointestinal Disease; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; MING-SHIANG WU; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; MING-SHIANG WU; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S. |
| 臺大學術典藏 |
2020-11-02T02:04:03Z |
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial
|
Helicobacter Consortium; Taiwan Gastrointestinal Disease; MING-SHIANG WU; El-Omar E.M.; Chuang E.Y.; Lu T.-P.; Lin J.-T.; Wu J.-Y.; Chen Y.-N.; Hsu W.-F.; Chen C.-Y.; Luo J.-C.; Yang T.-H.; Lee J.-Y.; Chen C.-C.; Liou J.-M.; Chen C.-C.; Chang C.-M.; Fang Y.-J.; Bair M.-J.; Chen P.-Y.; Chang C.-Y.; Hsu Y.-C.; Chen M.-J. |
| 臺大學術典藏 |
2020-10-26T11:34:42Z |
Meta-analysis of genome-wide association studies in East Asian-ancestry populations identifies four new loci for body mass index
|
Nabika T.; Lee J.; Lim W.-Y.; Gao Y.-T.; Takayanagi R.; Kang D.-H.; Wong T.Y.; Hsiung C.A.; Wu I.-C.; Chun B.-Y.; Young T.L.; Shin D.H.; Lee Y.-H.; Ji B.-T.; Shi J.; Choi B.Y.; Aung T.; Hu F.; Kim M.K.; Lim W.Y.; Wang T.-D.; Shin M.-H.; Lee J.; Zhu D.; Rotter J.I.; Qi L.; Chen Y.-D.I.; Taylor K.D.; Cho M.-C.; Han B.-G.; Hwu C.-M.; Assimes T.L.; Absher D.; Yan X.; Kim E.; Kuo J.Z.; Kwon S.; Wu T.; Mohlke K.L.; Gu D.; Mo Z.; Wu J.-Y.; Lin X.; Miki T.; Tai E.S.; Lee J.-Y.; Kato N.; Shu X.-O.; Tanaka T.; JYH-MING JIMMY JUANG; Lu W.; Sim X.; Kim B.-J.; Isono M.; Xiang Y.-B.; Seielstad M.; Hixson J.; Guo X.; Kubo M.; Yamamoto K.; Ohkubo T.; Go M.J.; Liu J.J.; Gan W.; Chen C.-C.; Gao Y.; Lu L.; Cho Y.S.; Ong R.T.; Takashima N.; Li S.; Lee N.R.; Wu C.; Zhou X.; Song H.; Yao J.; Lee I.-T.; Long J.; Tsunoda T.; Akiyama K.; Kim Y.J.; Umemura S.; Chen C.-H.; Tan A.; Rice T.K.; Adair L.S.; Gui L.; Allison M.; Lee W.-J.; Cai Q.; Isomura M.; He M.; Wu Y.; He J.; Yang X.; Tsai F.-J.; Li H.; Wen W.; Zheng W.; Okada Y.; Takeuchi F.; Tabara Y.; Hwang J.-Y.; Dorajoo R.; Delahanty R.; Sheu W.H.-H.; Guo X.; Zhang Y.; Liang J. |
| 臺大學術典藏 |
2020-10-26T11:34:35Z |
Association analyses of East Asian individuals and trans-ancestry analyses with European individuals reveal new loci associated with cholesterol and triglyceride levels
|
Kato N.; Jonas J.B.; Cheng C.Y.; Shu K.O.; He J.; Zheng W.; Wong T.-Y.; Huang W.; Kim B.J.; Tai E.S.; Mohlke K.L.; Sim X.; Spracklen C.N.; Chen P.; Kim Y.J.; Wang X.; Cai H.; Li S.; Long J.; Wu Y.; Wang Y.X.; Takeuchi F.; Wu J.-Y.; Jung K.-J.; Hu C.; Akiyama K.; Zhang Y.; Moon S.; Johnson T.A.; Li H.; Dorajoo R.; He M.; Cannon M.E.; Roman T.S.; Salfati E.; Lin K.-H.; Guo X.; Sheu W.H.; Absher D.; Adair L.S.; Assimes T.L.; Aung T.; Cai Q.; Chang L.C.; Chen C.-H.; Chien L.H.; Chuang L.M.; Chuang S.C.; Du S.; Fan Q.; Fann C.S.J.; Feranil A.B.; Friedlander Y.; Gordon-Larsen P.; Gu D.; Chen Y.T.; Gui L.; Guo Z.; Heng C.K.; Hixson J.; Hou X.; Hsiung C.A.; Hu Y.; Hwang M.Y.; Hwu C.M.; Isono M.; JYH-MING JIMMY JUANG; Khor C.C.; Kim Y.K.; Koh W.P.; Kubo M.; Lee I.E.; Lee S.-J.; Lee W.-J.; Liang K.-W.; Lim B.; Lim S.H.; Liu J.; Nabika T.; Pan W.H.; Peng H.; Quertermous T.; Sabanayagam C.; Sandow K.; Shi J.; Sun L.; Tan P.C.; Tan S.P.; Taylor K.D.; Teo Y.Y.; Toh S.A.; Tsunoda T.; van Dam R.M.; Wang A.; Wang F.; Wang J.; Wei W.B.; Xiang B.J.; Yao J.; Yuan J.M.; Zhang R.; Zhao W.; Ida Chen Y.-D.; Rich S.S.; Rotter J.I.; Wang T.D.; Wu T.; Lin X.; Han B.G.; Tanaka T.; Cho Y.S.; Katsuya T.; Jia W.; Jee S.H. |
| 臺大學術典藏 |
2020-10-23T12:12:40Z |
More evidence supports the association of PPP3CC with schizophrenia
|
Hwu H.-G.; Chen W.J.; Tsuang M.T.; Jou Y.S.; Faraone S.V.; Tsuang M.M.; Wu J.Y.; Hsieh M.H.; Liu C.C.; Liu Y.L.; Fann C.S.J.; Liu C.M.; Chang C.C.; Yang W.C.; Hung S.I.; Yu S.L.; TZUNG-JENG HWANG |
| 臺大學術典藏 |
2020-10-23T12:12:39Z |
Clustering by neurocognition for fine mapping of the schizophrenia susceptibility loci on chromosome 6p
|
TZUNG-JENG HWANG; Hsieh M.H.; Chang C.-C.; Yang W.-C.; Lin J.-J.; Chou F.H.-C.; Faraone S.V.; Tsuang M.T.; Hwu H.-G.; Chen W.J.; Lin S.-H.; Liu C.-M.; Liu Y.-L.; Shen-Jang Fann C.; Hsiao P.-C.; Wu J.-Y.; Hung S.-I.; Chen C.-H.; Wu H.-M.; Jou Y.-S.; Liu S.K. |
| 臺大學術典藏 |
2020-10-23T11:55:08Z |
Absence of significant associations between four AKT1 SNP markers and schizophrenia in the Taiwanese population
|
Liu Y.-L.;Fann C.S.-J.;Liu C.-M.;Wu J.-Y.;Hung S.-I.;Chan H.-Y.;Chen J.-J.;Pan C.-C.;Liu S.-K.;Hsieh M.H.;Tzung-Jeng Hwang;Ouyang W.-C.;Chen C.-Y.;Lin J.-J.;Chou F.H.-C.;Chueh C.-M.;Liu W.-M.;Tsuang M.-M.;Faraone S.V.;Tsuang M.T.;Chen W.J.;Hwu H.-G.; Liu Y.-L.; Fann C.S.-J.; Liu C.-M.; Wu J.-Y.; Hung S.-I.; Chan H.-Y.; Chen J.-J.; Pan C.-C.; Liu S.-K.; Hsieh M.H.; TZUNG-JENG HWANG; OuYang W.-C.; Chen C.-Y.; Lin J.-J.; Chou F.H.-C.; Chueh C.-M.; Liu W.-M.; Tsuang M.-M.; Faraone S.V.; Tsuang M.T.; Chen W.J.; Hwu H.-G. |
| 臺大學術典藏 |
2020-10-23T11:55:07Z |
No association of G72 and d-amino acid oxidase genes with schizophrenia
|
Hwu H.-G.; Liu Y.-L.;Fann C.S.-J.;Liu C.-M.;Chang C.C.;Wu J.-Y.;Hung S.-I.;Liu S.-K.;Hsieh M.H.;Tzung-Jeng Hwang;Chan H.-Y.;Chen J.-J.;Faraone S.V.;Tsuang M.T.;Chen W.J.;Hwu H.-G.; Liu Y.-L.; Fann C.S.-J.; Liu C.-M.; Chang C.C.; Wu J.-Y.; Hung S.-I.; Liu S.-K.; Hsieh M.H.; TZUNG-JENG HWANG; Chan H.-Y.; Chen J.-J.; Faraone S.V.; Tsuang M.T.; Chen W.J. |
| 臺大學術典藏 |
2020-10-23T11:55:07Z |
A Single Nucleotide Polymorphism Fine Mapping Study of Chromosome 1q42.1 Reveals the Vulnerability Genes for Schizophrenia, GNPAT and DISC1: Association with Impairment of Sustained Attention
|
Liu Y.-L.;Fann C.S.-J.;Liu C.-M.;Chen W.J.;Wu J.-Y.;Hung S.-I.;Chen C.-H.;Jou Y.-S.;Liu S.-K.;Tzung-Jeng Hwang;Hsieh M.H.;Ouyang W.-C.;Chan H.-Y.;Chen J.-J.;Yang W.-C.;Lin C.-Y.;Lee S.F.C.;Hwu H.-G.; Liu Y.-L.; Fann C.S.-J.; Liu C.-M.; Chen W.J.; Wu J.-Y.; Hung S.-I.; Chen C.-H.; Jou Y.-S.; Liu S.-K.; TZUNG-JENG HWANG; Hsieh M.H.; Ouyang W.-C.; Chan H.-Y.; Chen J.-J.; Yang W.-C.; Lin C.-Y.; Lee S.F.C.; Hwu H.-G. |
| 臺大學術典藏 |
2020-10-23T11:55:07Z |
Evaluation of RGS4 as a candidate gene for schizophrenia
|
Liu Y.-L.;Fann C.S.-J.;Liu C.-M.;Wu J.-Y.;Hung S.-I.;Chan H.-Y.;Chen J.-J.;Lin C.-Y.;Liu S.-K.;Hsieh M.H.;Tzung-Jeng Hwang;Ouyang W.-C.;Chen C.-Y.;Lin J.-J.;Chou F.H.-C.;Chueh C.-M.;Liu W.-M.;Tsuang M.-M.;Faraone S.V.;Tsuang M.T.;Chen W.J.;Hwu H.-G.; Liu Y.-L.; Fann C.S.-J.; Liu C.-M.; Wu J.-Y.; Hung S.-I.; Chan H.-Y.; Chen J.-J.; Lin C.-Y.; Liu S.-K.; Hsieh M.H.; TZUNG-JENG HWANG; OuYang W.-C.; Chen C.-Y.; Lin J.-J.; Chou F.H.-C.; Chueh C.-M.; Liu W.-M.; Tsuang M.-M.; Faraone S.V.; Tsuang M.T.; Chen W.J.; Hwu H.-G. |
| 臺大學術典藏 |
2020-10-23T11:55:05Z |
No association evidence between schizophrenia and dystrobrevin-binding protein 1 (DTNBP1) in Taiwanese families
|
Wu J.-Y.; Hung S.-I.; Chen W.J.; Chueh C.-M.; Liu W.-M.; Liu C.-C.; Hsieh M.-H.; TZUNG-JENG HWANG; Faraone S.V.; Tsuang M.T.; Hwu H.-G.; Liu C.-M.; Liu Y.-L.; Fann C.S.-J.; Yang W.-C. |
| 臺大學術典藏 |
2020-10-23T11:55:04Z |
RASD2, MYH9, and CACNG2 Genes at Chromosome 22q12 Associated with the Subgroup of Schizophrenia with Non-Deficit in Sustained Attention and Executive Function
|
Liu Y.-L.; Fann C.S.-J.; Liu C.-M.; Chen W.J.; Wu J.-Y.; Hung S.-I.; Chen C.-H.; Jou Y.-S.; Liu S.-K.; TZUNG-JENG HWANG; Hsieh M.H.; Chang C.C.; Yang W.-C.; Lin J.-J.; Chou F.H.-C.; Faraone S.V.; Tsuang M.T.; Hwu H.-G. |
| 臺大學術典藏 |
2020-10-23T11:55:04Z |
HTF9C gene of 22q11.21 region associates with schizophrenia having deficit-sustained attention
|
Liu Y.-L.;Fann C.S.-J.;Liu C.-M.;Ching Chang C.;Yang W.-C.;Wu J.-Y.;Hung S.-I.;Chan H.-Y.;Chen J.-J.;Hsieh M.H.;Tzung-Jeng Hwang;Faraone S.V.;Tsuang M.T.;Chen W.J.;Hwu H.-G.;Chung-Shan; Liu Y.-L.; Fann C.S.-J.; Liu C.-M.; Ching Chang C.; Yang W.-C.; Wu J.-Y.; Hung S.-I.; Chan H.-Y.; Chen J.-J.; Hsieh M.H.; TZUNG-JENG HWANG; Faraone S.V.; Tsuang M.T.; Chen W.J.; Hwu H.-G.; Chung-Shan |
| 臺大學術典藏 |
2020-10-23T11:55:04Z |
More evidence supports the association of PPP3CC with schizophrenia
|
Liu Y.L.; Fann C.S.J.; Liu C.M.; Chang C.C.; Yang W.C.; Hung S.I.; Yu S.L.; Hwang T.J.; Hsieh M.H.; Liu C.C.; Tsuang M.M.; Wu J.Y.; Jou Y.S.; Faraone S.V.; Tsuang M.T.; Chen W.J.; Hwu H.-G. |
| 臺大學術典藏 |
2020-10-23T11:55:03Z |
Clustering by neurocognition for fine mapping of the schizophrenia susceptibility loci on chromosome 6p
|
Faraone S.V.; Tsuang M.T.; Hwu H.-G.; Chen W.J.; Lin S.-H.; Liu C.-M.; Liu Y.-L.; Shen-Jang Fann C.; Hsiao P.-C.; Wu J.-Y.; Hung S.-I.; Chen C.-H.; Wu H.-M.; Jou Y.-S.; Liu S.K.; Chou F.H.-C.; Hwang T.J.; Hsieh M.H.; Chang C.-C.; Yang W.-C.; Lin J.-J. |
| 臺大學術典藏 |
2020-08-13T06:34:02Z |
Leg pains, clubbing of digits and lung mass: What is your call?
|
Wu J.-Y.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-08-13T06:34:00Z |
First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer
|
Wu J.-Y.; Yu C.-J.; Yang P.-C.; JIN-YUAN SHIH; Wei P.-F.; Hsu Y.-C.; Chang Y.-C.; Gow C.-H.; Yang C.-H.; Wu S.-G.; Chiu Y.-H. |
| 臺大學術典藏 |
2020-08-13T06:33:58Z |
Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer
|
JIN-YUAN SHIH; Yang C.-H.; Chen K.-Y.; Ho C.-C.; Yu C.-J.; Yang P.-C.; Wu J.-Y.; Wu J.-Y.;Jin-Yuan Shih;Yang C.-H.;Chen K.-Y.;Ho C.-C.;Yu C.-J.;Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:57Z |
Use of cetuximab after failure of gefitinib in patients with advanced non-small-cell lung cancer
|
Wu J.-Y.; Yang C.-H.; Hsu Y.-C.; Yu C.-J.; Chang S.-H.; JIN-YUAN SHIH; Yang P.-C.; Wu J.-Y.;Yang C.-H.;Hsu Y.-C.;Yu C.-J.;Chang S.-H.;Jin-Yuan Shih;Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:53Z |
Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations
|
Wu J.-Y.; Wu J.-Y.;Jin-Yuan Shih;Chen K.-Y.;Yang C.-H.;Yu C.-J.;Yang P.-C.; Yang P.-C.; JIN-YUAN SHIH; Chen K.-Y.; Yang C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-08-13T06:33:53Z |
Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations
|
Wu J.-Y.; Wu S.-G.; Yang C.-H.; Chang Y.-L.; Chang Y.-C.; Hsu Y.-C.; JIN-YUAN SHIH; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:52Z |
Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer
|
Wu J.-Y.; Yu C.-J.; Chang Y.-C.; Yang C.-H.; JIN-YUAN SHIH; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:38Z |
Effectiveness of tyrosine kinase inhibitors on uncommon E709X epidermal growth factor receptor mutations in non-small-cell lung cancer
|
JIN-YUAN SHIH; Wu J.-Y. |
| 臺大學術典藏 |
2020-08-13T06:33:25Z |
Effectiveness of Treatments for Advanced Non–Small-Cell Lung Cancer With Exon 20 Insertion Epidermal Growth Factor Receptor Mutations
|
Wu J.-Y.; Yu C.-J.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-08-12T08:25:31Z |
First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer
|
Wu J.-Y.; Yu C.-J.; Yang C.-H.; SHANG-GIN WU; Chiu Y.-H.; Gow C.-H.; Chang Y.-C.; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T08:25:31Z |
Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern
|
SHANG-GIN WU; Chang Y.-L.; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; Yu C.-J.; Tsai M.-F.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T08:25:31Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Wu J.-Y.; SHANG-GIN WU; Yang C.-H.; Gow C.-H.; Chang Y.-L.; Yu C.-J.; Shin J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T08:25:30Z |
Critical illness polyneuromyopathy in a patient with disseminated cryptococcal infection
|
Yang P.-C.; Kuo P.-H.; Wu J.-Y.; SHANG-GIN WU; Sun H.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:26Z |
Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis
|
Hu F.-C.; Chang Y.-L.; Lee Y.-C.; Yu C.-J.; Chang Y.-C.; Wu J.-Y.; Shih J.-Y.; Yang P.-C.; SHANG-GIN WU |
| 臺大學術典藏 |
2020-08-12T06:35:29Z |
Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer
|
Wu J.-Y.;Chong-Jen Yu;Shih J.-Y.;Yang C.-H.;Yang P.-C.; Wu J.-Y.; CHONG-JEN YU; Shih J.-Y.; Yang C.-H.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T06:35:23Z |
Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations
|
Yang P.-C.; Wu J.-Y.;Shih J.-Y.;Chen K.-Y.;Yang C.-H.;Chong-Jen Yu;Yang P.-C.; Wu J.-Y.; Shih J.-Y.; Chen K.-Y.; Yang C.-H.; CHONG-JEN YU |
| 臺大學術典藏 |
2020-08-12T06:35:22Z |
Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer
|
Wu J.-Y.;Chong-Jen Yu;Chang Y.-C.;Yang C.-H.;Shih J.-Y.;Yang P.-C.; Wu J.-Y.; CHONG-JEN YU; Chang Y.-C.; Yang C.-H.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T06:35:14Z |
Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR
|
Shih J.-Y.; Yang P.-C.; Wei P.-F.; Chung K.-P.;Wu S.-G.;Wu J.-Y.;Yang J.-H.;Chong-Jen Yu;Wei P.-F.;Shih J.-Y.;Yang P.-C.; Chung K.-P.; Wu S.-G.; Wu J.-Y.; Yang J.-H.; CHONG-JEN YU |
| 臺大學術典藏 |
2020-08-12T06:35:08Z |
Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis
|
Lee Y.-C.; CHONG-JEN YU; Chang Y.-C.; Wu J.-Y.; Shih J.-Y.; Yang P.-C.; Chang Y.-L.; Hu F.-C.; Wu S.-G.;Hu F.-C.;Chang Y.-L.;Lee Y.-C.;Chong-Jen Yu;Chang Y.-C.;Wu J.-Y.;Shih J.-Y.;Yang P.-C.; Wu S.-G. |
| 臺大學術典藏 |
2020-08-12T02:50:56Z |
Adrenal insufficiency in prolonged critical illness
|
Wu J.-Y.;Hsu S.-C.;Ku S.-C.;Chao-Chi Ho;Yu C.-J.;Yang P.-C.; Yang P.-C.; Wu J.-Y.; Hsu S.-C.; Ku S.-C.; CHAO-CHI HO; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:46:34Z |
Adrenal insufficiency in prolonged critical illness
|
Wu J.-Y.; Hsu S.-C.; Ku S.-C.; CHAO-CHI HO; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2020-07-21T06:46:33Z |
Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer
|
Wu J.-Y.; Shih J.-Y.; Yang C.-H.; Chen K.-Y.; CHAO-CHI HO; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2020-07-01T07:39:42Z |
Methyl-directed repair of mismatched small heterologous sequences in cell extracts from Escherichia coli
|
Woei-Horng Fang;Wu J.-Y.;Su M.-J.; WOEI-HORNG FANG; Wu J.-Y.; Su M.-J. |
| 臺大學術典藏 |
2020-06-30T05:45:19Z |
Regulation of cyst wall protein promoters by Myb2 in Giardia lamblia
|
Huang Y.-C.;Su L.-H.;Lee G.A.;Chiu P.-W.;Cho C.-C.;Wu J.-Y.;Chin-Hung Sun; Huang Y.-C.; Su L.-H.; Lee G.A.; Chiu P.-W.; Cho C.-C.; Wu J.-Y.; CHIN-HUNG SUN |
| 淡江大學 |
2020-05-31 |
Leveraging IT–Enabled Service Innovation in a Highly Competitive Market
|
Shang, S. S.-C.;Wu, Ya-Ling;Wu, J.-Y.;Chen, C.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:23Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Yang P.-C.;Shin J.-Y;Yu C.-J;Chang Y.-L;Gow C.-H;Chih-Hsin Yang;Wu S.-G;Wu J.-Y; Wu J.-Y; Wu S.-G; CHIH-HSIN YANG; Gow C.-H; Chang Y.-L; Yu C.-J; Shin J.-Y; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:21Z |
First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer
|
Yang P.-C.;Shih J.-Y;Wei P.-F;Hsu Y.-C;Chang Y.-C;Gow C.-H;Chiu Y.-H;Wu S.-G;Chih-Hsin Yang;Yu C.-J;Wu J.-Y; Wu J.-Y; Yu C.-J; CHIH-HSIN YANG; Wu S.-G; Chiu Y.-H; Gow C.-H; Chang Y.-C; Hsu Y.-C; Wei P.-F; Shih J.-Y; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:21Z |
Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern
|
Yang P.-C.;Shih J.-Y;Tsai M.-F;Yu C.-J;Chih-Hsin Yang;Wu J.-Y;Hsu Y.-C;Chang Y.-L;Wu S.-G; Wu S.-G; Chang Y.-L; Hsu Y.-C; Wu J.-Y; CHIH-HSIN YANG; Yu C.-J; Tsai M.-F; Shih J.-Y; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:18Z |
Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer
|
Wu J.-Y;Shih J.-Y;Chih-Hsin Yang;Chen K.-Y;Ho C.-C;Yu C.-J;Yang P.-C.; Wu J.-Y; Shih J.-Y; CHIH-HSIN YANG; Chen K.-Y; Ho C.-C; Yu C.-J; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:16Z |
Use of cetuximab after failure of gefitinib in patients with advanced non-small-cell lung cancer
|
Shih J.-Y; Chang S.-H; Yu C.-J; Hsu Y.-C; CHIH-HSIN YANG; Wu J.-Y; Wu J.-Y;Chih-Hsin Yang;Hsu Y.-C;Yu C.-J;Chang S.-H;Shih J.-Y;Yang P.-C.; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:16Z |
Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer
|
Wu J.-Y;Yu C.-J;Shih J.-Y;Chih-Hsin Yang;Yang P.-C.; Wu J.-Y; Yu C.-J; Shih J.-Y; CHIH-HSIN YANG; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:13Z |
Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations
|
Wu J.-Y;Wu S.-G;Chih-Hsin Yang;Chang Y.-L;Chang Y.-C;Hsu Y.-C;Shih J.-Y;Yang P.-C.; Wu J.-Y; Wu S.-G; CHIH-HSIN YANG; Chang Y.-L; Chang Y.-C; Hsu Y.-C; Shih J.-Y; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:12Z |
Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations
|
Wu J.-Y;Shih J.-Y;Chen K.-Y;Chih-Hsin Yang;Yu C.-J;Yang P.-C.; Wu J.-Y; Shih J.-Y; Chen K.-Y; CHIH-HSIN YANG; Yu C.-J; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:12Z |
Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer
|
Wu J.-Y;Yu C.-J;Chang Y.-C;Chih-Hsin Yang;Shih J.-Y;Yang P.-C.; Wu J.-Y; Yu C.-J; Chang Y.-C; CHIH-HSIN YANG; Shih J.-Y; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:07Z |
Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR
|
Yang P.-C.;Shih J.-Y;Wei P.-F;Yu C.-J;Chih-Hsin Yang;Wu J.-Y;Wu S.-G;Chung K.-P; Chung K.-P; Wu S.-G; Wu J.-Y; CHIH-HSIN YANG; Yu C.-J; Wei P.-F; Shih J.-Y; Yang P.-C. |
